Mark Anderson
Our mission is to bring Health equality to the world.
Goals
To be the preferred choice for commercial pharma data analytics vendor in the market, owing to ease of use, powerful and efficient data solutions.
Help small and medium-sized pharma companies prepare for successful drug launches through optimised data analytics software.
Be the leading provider of formulary data and care pathway to Pharma and healthcare organisations in the world.
Tell us about yourself?
Manoranjan Das is a Business Intelligence professional with 26 years of experience. He has led business intelligence practices for many global leading organisations with P & L responsibility.
He is engaged in delivering multiple and multi-faceted data warehouses, data migration and business intelligence solutions within Government, Utility, Manufacturing, Banking, Insurance and Healthcare sectors.
He possesses extensive knowledge in data management, BI Competency Centre setup, data governance, data migration, and understanding of various products and technology.
He is a chartered member of the British Computer Society, a certified software quality professional and Prince II certified. Academically he holds a postgraduate degree in Planning and a graduate in engineering. It is my passion to make data as driver of decision making in the world of healthcare.
My training and experience in data in the Life science industry, made me think as a sweet spot to start with.
If you could go back in time a year or two, what piece of advice would you give yourself?
Focus on sales even if you don’t have a product. And, ‘Don’t be a slow burner of your effort and money’ – as a start-up owner.
What problem does your business solve?
There’s a lot of competition for healthcare money and just because a pharma company has developed an innovative drug, doesn’t guarantee anyone will buy the product.
More than 60% of the pharmaceutical drugs fail to meet their expectations in the commercialisation phase.
An often-overlooked hurdle is a strategic launch and commercialisation plan. Allot’s analytics platform helps in the commercialisation of drugs by assisting in commercial planning and field force management.
What is the inspiration behind your business?
Only eight countries in the globe through which the pharma companies mostly release their speciality drugs.
This causes health inequality around the world by depriving many people of access to advanced medication and patient pathways.
As Allot, we are cost-effectively developing the platform and processes to help Pharma and biotech companies market launch and commercialise their products.
Our primary target market is Small and medium Pharma or Biotech companies anywhere in the world. We will help them market launch and commercialise their drugs or devices.
What is your magic sauce?
Our magic sauce is one stop shop for all analytical needs of a commercial launch. Our differences: OUR USPs: #PaaS – Cloud platform targeted at pharma and biotech sector. #Data supply:
We will collect formulary and all the public domain data to help in analysis without asking for third party supply. #Time to market: We promise deliverables in the very first month.
What is the plan for the next 5 years? What do you want to achieve?
We have already deployed our platform and services for European countries.
We want to take our platform to the USA, South America and Asian countries in the next five years. Also, we want to add further localisation to our solutions and framework.
Our vision is to be the sought-after company for all commercial launches of Pharma and Biotech companies.
What is the biggest challenge you’ve faced so far?
The biggest challenge is retaining the talents we train in our company and customer acquisition. To sustain our company financially we have changed the course in between in tactical way.
How do people get involved/buy into your vision?
We want small and medium pharma/biotech companies to reach out to us and experience our cloud platform in a no obligation trial of their situation.
